Kaletra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of Hydroxychloroquine + Favipiravir Drug Regimen in Comparison With Hydroxychloroquine + Kaletra on the Need for Intensive Care Unit Treatment in Patients With COVID-19
Conditions:   COVID-19;   Favipiravir;   Kaletra;   Hydroxychloroquine Interventions:   Drug: Favipiravir;   Drug: Hydroxychloroquine;   Drug: Kaletra Sponsor:   Baqiyatallah Medical Sciences University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2020 Category: Research Source Type: clinical trials

Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19
Condition:   SARS Coronavirus 2 Infection Interventions:   Drug: Baricitinib;   Drug: Hydroxychloroquine;   Drug: Lopinavir/Ritonavir;   Drug: Remdesivir Sponsors:   University of Southern California;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2020 Category: Research Source Type: clinical trials